Analyst Reco. CSL Limited OTC Markets

Equities

CSLLY

US12637N2045

Market Closed - OTC Markets Other stock markets 20:53:11 31/05/2024 BST			5-day change	1st Jan Change
94.11 ^USD	+1.48%		+0.83%	-3.01%

05-30	US nears deal to fund Moderna's bird flu vaccine trial, FT reports	RE
05-27	US, European nations consider vaccinating workers exposed to bird flu	RE

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Morgan Stanley Adjusts CSL’s Price Target to AU$310 From AU$318, Keeps at Overweight	03-06	MT
Jarden Research CSL’s Price Target to AU$296.02 From AU$298.57, Keeps at Overweight	02-14	MT
Jarden Research Adjusts CSL’s Price Target to AU$298.57 From AU$316.16, Keeps at Overweight	02-13	MT
Australian shares post first weekly fall in three as rate-hike bets back in focus	02-09	RE
Australian shares climb as slow economic growth allays rate-hike fears	12-06	RE
Financials push Australian shares higher after RBA keeps cash rate steady	12-06	RE
Australian shares hit 1-week high on miners' boost; Fed rate decision in focus	14/06/23	RE
Arcturus Therapeutics Shares Rise 31% After Vaccine Collaboration	02/11/22	DJ
Fitch Withdraws Vifor's Ratings on Acquisition by CSL	26/08/22	AQ
Australia shares flat as miners offset CSL drag, NZ falls ahead of rates decision	17/08/22	RE
Australia shares slump as inflation woes hint at more rate hikes	06/05/22	RE
S&P/ASX 200 : Australian Shares Struggle for Direction Amid Mixed Earnings Results; Unemployment Rate Decreases in January	18/02/21	MT
National Australia Bank : Australia shares wobble ahead of cenbank rate decision; NZ falls	31/08/20	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer